Shorts

0:32
CLL17 3-Year Update: Who May Benefit From Continuous Therapy?
8 months ago
by
Nicole Lamanna, MD

1:00
Bringing Clinical Trials Into the Community
8 months ago
by
Danny Nguyen, MD

0:43
Early-Onset CRC: Thinking Beyond the Tumor
8 months ago
by
Patrick Boland, MD

0:46
How AI is Revolutionizing Clinical Trials
8 months ago
by
Danny Nguyen, MD

0:57
Why Clinical Trials Aren't Just a Last Resort for Cancer
8 months ago
by
Danny Nguyen, MD

0:55
Big Shifts Ahead in Lung Cancer: New KRAS Data and Paradigm Changes
8 months ago
by
Christine Bestvina, MD

0:28
Decentralized Clinical Trials: Reducing the Logistical Burden of Participation
8 months ago
by
Inna Gong, MD, PhD

1:18
Why Women Face Longer Delays in Lung Cancer Diagnosis
8 months ago
by
Narjust Florez, MD

0:57
A “Cancer Genome Atlas” for Immune Profiles?
8 months ago
by
Won Jin Ho, MD

0:32
Confronting Feelings of Guilt in Younger Patients
8 months ago
by
Narjust Florez, MD

0:51
Why Young Women's Lung Cancer Symptoms Are Often Ignored
8 months ago
by
Narjust Florez, MD

1:07
Why ZIP Code Shouldn't Determine Cancer Outcomes
8 months ago
by
Pallav K. Mehta, MD(+1 more)

0:52
Guideline Updates in Lymphoma Treatment
8 months ago
by
Hua-Jay "Jeff" Cherng, MD

0:31
Why You Shouldn't Wait to Treat MDS
8 months ago
by
David Sallman, MD

0:32
My Strategy for MDS Patients Waiting Transplant
8 months ago
by
David Sallman, MD

0:50
Why Haven't Trial Participation Rates Improved?
8 months ago
by
Inna Gong, MD, PhD

0:55
Combating Misinformation: The Truth About the HPV Vaccine
8 months ago
by
Natalie Berger, MD

0:30
Are We Being Too Strict With Clinical Trial Eligibility?
8 months ago
by
Christine Bestvina, MD

0:33
Why Lung Cancer is Now "12 Different Diseases"
8 months ago
by
Christine Bestvina, MD

1:04
MajesTEC-3 Outcomes Lead to Rapid Myeloma Combo Approval
8 months ago
by
Luciano Costa, MD, PhD

0:47
The Problem With MRD Testing in Breast Cancer
8 months ago
by
Paolo Tarantino, MD

1:30
How Mezigdomide Reinvigorates the Immune System
8 months ago
by
Paul G. Richardson, MD

0:31
Mapping Therapy-Driven Immune Changes in Metastatic PDAC
8 months ago
by
Won Jin Ho, MD

1:08
Is 2026 the Pivotal Year for Liquid Biopsies in Breast Cancer?
8 months ago
by
Paolo Tarantino, MD

0:39
Overlaps in Breast and Gynecologic Cancer Treatments
8 months ago
by
Natalie Berger, MD

0:34
The Future of Personalized Kidney Cancer Treatment
8 months ago
by
Karie Runcie, MD

1:30
Predicting Melanoma Treatment Success After 3-4 Weeks
8 months ago
by
Vincent Ma, MD

0:55
Intravesical Erdafitinib Evaluated in Phase 1 NMIBC Trial
8 months ago
by
Antoni Vilaseca Cabo, MD

0:42
Exploring Immune Data to Guide Pancreatic Cancer Immunotherapy
8 months ago
by
Won Jin Ho, MD

0:41
How MRD Could Fast-Track Cancer Breakthroughs
8 months ago
by
Sagar Lonial, MD, FACP
Advertisement
Advertisement
Trending on Targeted Onc
1
FDA Approves Neladalkib for Previously Treated Advanced ALK-Positive NSCLC
2
Galinpepimut-S Improves Overall Survival in Phase 3 REGAL Trial in AML
3
FDA Approves Giredestrant Plus Everolimus in ESR1-Mutated Breast Cancer
4
FDA Fast Tracks Elticertinib for Previously Treated EGFR Exon 20 NSCLC
5
